Nick Sheron
Overview
Explore the profile of Nick Sheron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
3095
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Edmunds C, Gold N, Burton R, Smolar M, Walmsley M, Henn C, et al.
BMC Public Health
. 2025 Mar;
25(1):989.
PMID: 40082809
No abstract available.
2.
Arab J, Diaz L, Rehm J, Im G, Arrese M, Kamath P, et al.
J Hepatol
. 2024 Nov;
PMID: 39608457
In this position statement, we explore the intricate relationship between alcohol intake and metabolic dysfunction in the context of the 2023 nomenclature update for steatotic liver disease (SLD). Recent and...
3.
Sharpe C, Bhuptani S, Jecks M, Sheron N, Henn C, Burton R
JMIR Form Res
. 2024 Jun;
8:e54587.
PMID: 38941596
Background: Higher availability of alcohol is associated with higher levels of alcohol consumption and harm. Alcohol is increasingly accessible online, with rapid delivery often offered by a third-party driver. Remote...
4.
Burton R, Sharpe C, Bhuptani S, Jecks M, Henn C, Pearce-Smith N, et al.
BMC Public Health
. 2024 May;
24(1):1286.
PMID: 38730332
Background: The WHO highlight alcohol, tobacco, unhealthy food, and sugar-sweetened beverage (SSB) taxes as one of the most effective policies for preventing and reducing the burden of non-communicable diseases. This...
5.
Hagstrom H, Adams L, Allen A, Byrne C, Chang Y, Duseja A, et al.
Hepatol Commun
. 2024 Feb;
8(2).
PMID: 38315102
Background: Following the adoption of new nomenclature for steatotic liver disease, we aimed to build consensus on the use of International Classification of Diseases codes and recommendations for future research...
6.
Retat L, Webber L, Jepsen P, Martin A, Cortez-Pinto H, Lazarus J, et al.
J Hepatol
. 2023 Dec;
80(4):543-552.
PMID: 38092157
Background & Aims: Chronic liver disease (CLD) causes 1.8% of all deaths in Europe, many of them from liver cancer. We estimated the impact of several policy interventions in France,...
7.
Burton R, Sharpe C, Sheron N, Henn C, Knight S, Wright V, et al.
Prev Med
. 2023 Aug;
175:107683.
PMID: 37633599
Background: The aim of this study was to examine the prevalence and clustering of four health risks (increasing-/higher-risk drinking, current smoking, overweight/obesity, and at-risk gambling), and to examine variation across...
8.
Edmunds C, Gold N, Burton R, Smolar M, Walmsley M, Henn C, et al.
BMC Public Health
. 2023 Jul;
23(1):1458.
PMID: 37525214
Background: Consumers have difficulty understanding alcoholic units and low risk drinking guidelines (LRDG). Labelling may improve comprehension. The aims of this rapid evidence review were to establish the effectiveness of...
9.
Dhanda A, Bodger K, Hood S, Henn C, Allison M, Amasiatu C, et al.
Aliment Pharmacol Ther
. 2022 Nov;
57(4):368-377.
PMID: 36397658
Background: Emergency admissions in England for alcohol-related liver disease (ArLD) have increased steadily for decades. Statistics based on administrative data typically focus on the ArLD-specific code as the primary diagnosis...
10.